| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |